Skip to main content
logo
Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland flag Poland · Delayed Price · Currency is PLN
78.90
+1.90 (2.47%)
Jun 12, 2026, 5:00 PM CET

WSE:CTX Revenue

Captor Therapeutics Spolka Akcyjna had revenue of 328.00K PLN in the quarter ending March 31, 2026, a decrease of -87.41%. This brings the company's revenue in the last twelve months to 2.38M, down -82.90% year-over-year. In the year 2025, Captor Therapeutics Spolka Akcyjna had annual revenue of 4.66M, down -70.55%.

Revenue (ttm)
2.38M
Revenue Growth
-82.90%
P/S Ratio
210.45
Revenue / Employee
29.05K
Employees
82
Market Cap
501.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.66M-11.17M-70.55%
Dec 31, 202415.83M2.62M19.88%
Dec 31, 202313.20M4.04M44.15%
Dec 31, 20229.16M5.17M129.75%
Dec 31, 20213.99M--
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BIOTON266.02M
Ryvu Therapeutics88.38M
Synthaverse42.19M
Mabion17.61M
Molecure6.52M
Urteste2.50M
Pharmena1.61M
Poltreg250.00K
Revenue Rankings

Captor Therapeutics Spolka Akcyjna News

More News